Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2026)

Updated

Tg Therapeutics' Long-Term Debt Issuances was $747.66 million in Q1 2026.

Analysis

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2026) Analysis & Trends

For FY2024, Long-Term Debt Issuances at Tg Therapeutics came in at $244.82 million, up 879.3% from FY2023.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of 52.2% (FY2019 to FY2024).
  • In earlier years, Long-Term Debt Issuances was $25 million in FY2023 and $70 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Long-Term Debt Issuances since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 747.66 Mn
Sep 30, 2024 244.82 Mn
Mar 31, 2023 25.00 Mn
Dec 31, 2019 312,000.00
Sep 30, 2019 -4,000.00
Jun 30, 2019 -61,000.00
Mar 31, 2019 29.74 Mn
API Access

Tg Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TGTX&period=max&api_key=YOUR_API_KEY